SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from InspireMD, Inc. (NSPR) (CIK 0001433607) (NSPR) — Apr 10, 2013

InspireMD, Inc. (NSPR) (CIK 0001433607)
Date: April 10, 2013 · CIK: 0001433607 · Accession: 0001144204-13-021043

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-184066

Date
September 24, 2012
Author
Managing Director
Form
CORRESP
Company
InspireMD, Inc. (NSPR) (CIK 0001433607)

Letter

Re: InspireMD, Inc.

April 10, 2013

U.S. Securities and Exchange Commission

F. Street, NE

Washington, D.C. 20549

Registration Statement on Form S-1

Filed September 24, 2012

File No. 333-184066

VIA FACSIMILE

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, Cowen and Company, LLC, as representative of the underwriters, hereby requests acceleration of the effective date of the above-referenced Registration Statement so that it will become effective at 4:30 p.m., Washington D.C. time, on April 10, 2013, or as soon thereafter as practicable.

The following is supplemental information supplied under Rule 418(a)(7) and Rule 460 under the Securities Act of 1933:

(i) Date of preliminary prospectus: April 9, 2013

(ii) Dates of distribution: The preliminary prospectus dated April 9, 2013 was distributed from April 9, 2013 to April 10, 2013.

(iii) Number of prospective underwriters and dealers to whom preliminary prospectuses were furnished: 2

(iv) Number of prospectuses so distributed: 150

The undersigned confirms that it has complied with and will continue to comply with, and it has been informed or will be informed by participating dealers that they have complied with or will comply with, Rule 15c2-8 promulgated under the Securities Exchange Act of 1934, as amended, in connection with the above-referenced issue.

COWEN AND COMPANY, LLC

By: /s/ Jason Fenton

Name: Jason Fenton

Title: Managing Director

Show Raw Text
CORRESP
1
filename1.htm

April
10, 2013

U.S.
Securities and Exchange Commission

100
F. Street, NE

Washington,
D.C. 20549

    Re:
    InspireMD, Inc.

    Registration Statement on
    Form S-1

    Filed September 24, 2012

    File No. 333-184066

VIA
FACSIMILE

Ladies
and Gentlemen:

Pursuant
to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933,
as amended, Cowen and Company, LLC, as representative of the underwriters, hereby requests acceleration of the effective date
of the above-referenced Registration Statement so that it will become effective at 4:30 p.m., Washington D.C. time, on April 10,
2013, or as soon thereafter as practicable.

The
following is supplemental information supplied under Rule 418(a)(7) and Rule 460 under the Securities Act of 1933:

(i)	Date
of preliminary prospectus: April 9, 2013

(ii)	Dates
of distribution: The preliminary prospectus dated April 9, 2013 was distributed from April 9, 2013 to April 10, 2013.

(iii)	Number
of prospective underwriters and dealers to whom preliminary prospectuses were furnished: 2

(iv)	Number
of prospectuses so distributed: 150

The
undersigned confirms that it has complied with and will continue to comply with, and it has been informed or will be informed
by participating dealers that they have complied with or will comply with, Rule 15c2-8 promulgated under the Securities Exchange
Act of 1934, as amended, in connection with the above-referenced issue.

COWEN
AND COMPANY, LLC

    By:
    /s/
    Jason Fenton

    Name:
    Jason Fenton

    Title:
    Managing Director